Alexander Stratford

664 total citations
24 papers, 554 citations indexed

About

Alexander Stratford is a scholar working on Clinical Psychology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Alexander Stratford has authored 24 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Clinical Psychology, 14 papers in Organic Chemistry and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Alexander Stratford's work include Psychedelics and Drug Studies (22 papers), Chemical synthesis and alkaloids (14 papers) and Biochemical Analysis and Sensing Techniques (11 papers). Alexander Stratford is often cited by papers focused on Psychedelics and Drug Studies (22 papers), Chemical synthesis and alkaloids (14 papers) and Biochemical Analysis and Sensing Techniques (11 papers). Alexander Stratford collaborates with scholars based in United Kingdom, United States and Netherlands. Alexander Stratford's co-authors include Simon D. Brandt, Adam L. Halberstadt, Folker Westphal, Pierce V. Kavanagh, Jason Wallach, Simon Elliott, David E. Nichols, Lea Wagmann, Markus R. Meyer and Geraldine Dowling and has published in prestigious journals such as Psychopharmacology, Neuropharmacology and Analytical and Bioanalytical Chemistry.

In The Last Decade

Alexander Stratford

24 papers receiving 531 citations

Peers

Countries citing papers authored by Alexander Stratford

Since Specialization

Citations

This map shows the geographic impact of Alexander Stratford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Stratford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Stratford more than expected).

Fields of papers citing papers by Alexander Stratford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Stratford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Stratford. The network helps show where Alexander Stratford may publish in the future.

Co-authorship network of co-authors of Alexander Stratford

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Stratford. A scholar is included among the top collaborators of Alexander Stratford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Stratford. Alexander Stratford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Analytical and Pharmacological Characterization of 1‐(Furan‐2‐Carbonyl)‐LSD (1F‐LSD) and Comparison With 1‐(Thiophene‐2‐Carbonyl)‐LSD (1T‐LSD) 2024 ·Drug Testing and Analysis ·Simon D. Brandt, Pierce V. Kavanagh, (unknown), Simon Elliott, Alexander Stratford, Adam L. Halberstadt	3
2	Analytical and behavioral characterization of 1‐dodecanoyl‐LSD (1DD‐LSD) 2024 ·Drug Testing and Analysis ·Pierce V. Kavanagh, Folker Westphal, (unknown), Simon Elliott, Alexander Stratford, Adam L. Halberstadt, Simon D. Brandt	6
3	Analytical and behavioral characterization of 1‐hexanoyl‐LSD (1H‐LSD) 2024 ·Drug Testing and Analysis ·Simon D. Brandt, Pierce V. Kavanagh, (unknown), Alexander Stratford, Adam L. Halberstadt	3
4	Analytical and behavioral characterization of N‐ethyl‐N‐isopropyllysergamide (EIPLA), an isomer of N⁶–ethylnorlysergic acid N,N‐diethylamide (ETH‐LAD) 2023 ·Drug Testing and Analysis ·Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal, (unknown), (unknown), Alexander Stratford, Volker Auwärter, Adam L. Halberstadt	3
5	Analytical profile of the lysergamide 1cP‐AL‐LAD and detection of impurities 2022 ·Drug Testing and Analysis ·Pierce V. Kavanagh, Folker Westphal, (unknown), (unknown), Alexander Stratford, Volker Auwärter, Stephen J. Chapman, Adam L. Halberstadt, Simon D. Brandt	6
6	Return of the lysergamides. Part VII: Analytical and behavioural characterization of 1‐valeroyl‐d‐lysergic acid diethylamide (1V‐LSD) 2021 ·Drug Testing and Analysis ·Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal, (unknown), (unknown), Alexander Stratford, Geraldine Dowling, Adam L. Halberstadt	16
7	Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1‐cyclopropanoyl‐d‐lysergic acid diethylamide (1CP‐LSD) 2020 ·Drug Testing and Analysis ·Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal, Alexander Stratford, (unknown), Adam K. Klein, Geraldine Dowling, Nicola M. Dempster, Jason Wallach, Torsten Passie, Adam L. Halberstadt	31
8	Pharmacokinetics and subjective effects of 1P‐LSD in humans after oral and intravenous administration 2020 ·Drug Testing and Analysis ·(unknown), (unknown), Simon D. Brandt, Alexander Stratford, Torsten Passie, Volker Auwärter	16
9	Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of -lysergic acid diethylamide (LSD) 2019 ·Neuropharmacology ·Adam L. Halberstadt, Muhammad Chatha, Adam K. Klein, John D. McCorvy, Markus R. Meyer, Lea Wagmann, Alexander Stratford, Simon D. Brandt	29
10	In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures 2019 ·Analytical and Bioanalytical Chemistry ·Lea Wagmann, Lilian H.J. Richter, (unknown), (unknown), Madeleine Pettersson Bergstrand, Simon D. Brandt, Alexander Stratford, Hans H. Maurer, Markus R. Meyer	46
11	Validation of an LC-MS/MS method for the quantitative analysis of 1P-LSD and its tentative metabolite LSD in fortified urine and serum samples including stability tests for 1P-LSD under different storage conditions 2019 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), (unknown), Alexander Stratford, Maren Hermanns‐Clausen, Torsten Passie, Simon D. Brandt, Volker Auwärter	20
12	Return of the lysergamides. Part V: Analytical and behavioural characterization of 1‐butanoyl‐d‐lysergic acid diethylamide (1B‐LSD) 2019 ·Drug Testing and Analysis ·Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal, Alexander Stratford, (unknown), Geraldine Dowling, Jason Wallach, Adam L. Halberstadt	54
13	Phenethylamine‐derived new psychoactive substances 2C‐E‐FLY, 2C‐EF‐FLY, and 2C‐T‐7‐FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings 2019 ·Drug Testing and Analysis ·Lea Wagmann, (unknown), Lilian H.J. Richter, Simon D. Brandt, Alexander Stratford, Markus R. Meyer	12
14	In vitro toxicokinetics and analytical toxicology of three novel NBOMe derivatives: phase I and II metabolism, plasma protein binding, and detectability in standard urine screening approaches studied by means of hyphenated mass spectrometry 2019 ·Forensic Toxicology ·Lilian H.J. Richter, (unknown), Lea Wagmann, Simon D. Brandt, Alexander Stratford, Folker Westphal, Veit Flockerzi, Markus R. Meyer	12
15	Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA) 2018 ·Psychopharmacology ·Adam L. Halberstadt, (unknown), Muhammad Chatha, (unknown), Alexander Stratford, Jason Wallach, David E. Nichols, Simon D. Brandt	24
16	Comparison of the behavioral responses induced by phenylalkylamine hallucinogens and their tetrahydrobenzodifuran (“FLY”) and benzodifuran (“DragonFLY”) analogs 2018 ·Neuropharmacology ·Adam L. Halberstadt, Muhammad Chatha, Alexander Stratford, (unknown), Simon D. Brandt	21
17	Interactions of phenethylamine‐derived psychoactive substances of the 2C‐series with human monoamine oxidases 2018 ·Drug Testing and Analysis ·Lea Wagmann, Simon D. Brandt, Alexander Stratford, Hans H. Maurer, Markus R. Meyer	16
18	Return of the lysergamides. Part III: Analytical characterization of N⁶‐ethyl‐6‐norlysergic acid diethylamide (ETH‐LAD) and 1‐propionyl ETH‐LAD (1P–ETH‐LAD) 2017 ·Drug Testing and Analysis ·Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal, Simon Elliott, Jason Wallach, Alexander Stratford, David E. Nichols, Adam L. Halberstadt	41
19	Return of the lysergamides. Part II: Analytical and behavioural characterization of N⁶‐allyl‐6‐norlysergic acid diethylamide (AL‐LAD) and (2’S,4’S)‐lysergic acid 2,4‐dimethylazetidide (LSZ) 2016 ·Drug Testing and Analysis ·Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal, Simon Elliott, Jason Wallach, (unknown), Timothy E. Burrow, Stephen J. Chapman, Alexander Stratford, David E. Nichols, Adam L. Halberstadt	55
20	Return of the lysergamides. Part I: Analytical and behavioural characterization of 1‐propionyl‐d‐lysergic acid diethylamide (1P‐LSD) 2015 ·Drug Testing and Analysis ·Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal, Alexander Stratford, Simon Elliott, (unknown), Jason Wallach, Adam L. Halberstadt	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact